CCL2 and metabolic dysfunction-associated steatohepatitis: No significant differences in CCL2 levels measured in the NASH model were observed between the vehicle and CVC20 groups, while a significant increase in plasma CCL2 levels was observed in the CVC100 group compared with the vehicle group (vehicle, 60±4 pg/mL; CVC20, 68±16 pg/mL; CVC100, 91±14 pg/mL).